The Associations of Naturalistic Classic Psychedelic Use, Mystical Experience, and Creative Problem Solving

References

• Adamson, R. E. 1952. Functional fixedness as related to problem solving: A repetition of three experiments. Journal of Experimental Psychology 44 (4):288–91. doi:10.1037/h0062487.
   PubMedGoogle Scholar
• Arnon, R., and S. Kreitler. 1984. Effects of meaning training on overcoming functional fixedness. Current Psychology 3 (4):11–24. doi:10.1007/BF02686553.
   Google Scholar
• Baggott, M. 2015. Psychedelics and creativity: A review of the quantitative literature. PeerJ PrePrints 3:e1468. doi:10.7287/peerj.preprints.1202v1.
   PubMedGoogle Scholar
• Bogenschutz, M., A. A. Forcehimes, J. A. Pommy, C. E. Wilcox, P. C. R. Barbosa, and R. J. Strassman. 2015. Psilocybin-assisted treatment for alcohol-dependence: A proof of concept study. Journal of Psychopharmacology 29 (3):289–99. doi:10.1177/0269881114565144.
   PubMed Web of Science ®Google Scholar
• Bogenschutz, M., and M. Johnson. 2015. Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 64:250–58. doi:10.1016/j.pnpbp.2015.03.002.
   PubMed Web of Science ®Google Scholar
• Bouso, J. C., F. Palhano-Fontes, A. Rodríguez-Fornells, S. Ribeiro, R. Sanches, J. A. S. Cripp, J. E. C. Hallak, D. B. De Araujoc, and J. Riba. 2015. Long-term use of psychedelics is associated with differences in brain structure and personality in humans. European Neuropsychopharmacology 25 (4):483–92. doi:10.1016/j.euroneuro.2015.01.008.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R., M. Bolstridge, J. Rucker, C. M. J. Day, D. Erritzoe, M. Kaelen, M. Bloomfield, J. A. Rickard, B. Forbes, A. Feilding, D. Taylor, S. Pilling, V. H. Curran, and D. J. Nutt. 2016. Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry 3 (7):619–27. doi:10.1016/S2215-0366(16)30065-7.
   PubMed Web of Science ®Google Scholar
• Carhart-Harris, R., R. Leech, P. J. Hellyer, M. Shanahan, A. Feilding, E. Tagliazucchi, D. R. Chialvo, and D. J. Nutt. 2014. The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs. Frontiers in Human Neuroscience 3:8–20. doi:10.3389/fnhum.2014.00020.
   Web of Science ®Google Scholar
• Ding, X., Y. Tang, R. Tang, and M. Posner. 2014. Improving creativity performance by short-term meditation. Behavioral and Brain Functions 10:9. doi:10.1186/1744-9081-10-9.
   PubMed Web of Science ®Google Scholar
• Doblin, R. 1991. Pahnke’s “Good Friday experiment”: A long-term follow-up and methodological critique. Journal of Transpersonal Psychology 23 (1):1–28.
   Google Scholar
• Duncker, K. 1945. On problem solving. Psychological Monographs 58 (5):i–113. doi:10.1037/h0093599.
   Google Scholar
• Fadiman, J. 2011. The psychedelic explorer’s guide. Rochester, VT: Park Street Press.
   Google Scholar
• Fink, E. 2015. When Silicon Valley takes LSD. http://money.cnn.com/2015/01/25/technology/lsd-psychedelics-silicon-valley/ ( accessed March 4, 2016).
   Google Scholar
• Frati, P., C. Kyriakou, A. Del Rio, E. Marinelli, G. M. Vergallo, S. Zaami, and F. P. Busardò. 2015. Smart drugs and synthetic androgens for cognitive and physical enhancement: Revolving doors of cosmetic neurology. Current Neuropharmacology 13 (1):5–11. doi:10.2174/1570159X13666141210221750.
   PubMed Web of Science ®Google Scholar
• Garcia-Romeu, A., R. R. Griffiths, and M. Johnson. 2015. Psilocybin occasioned mystical experiences in the treatment of tobacco addiction. Current Drug Abuse Reviews 7 (3):157–64. doi:10.2174/1874473708666150107121331.
   Google Scholar
• Gasser, P., D. Holstein, Y. Michel, R. Doblin, B. Yazar-Klosinski, T. Passie, and R. Brenneisen. 2014. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. The Journal of Nervous and Mental Disease 202 (7):513–20. doi:10.1097/NMD.0000000000000113.
   PubMed Web of Science ®Google Scholar
• German, T. P., and H. C. Barrett. 2005. Functional fixedness in a technologically sparse culture. Psychological Science 16 (1):1–5. doi:10.1111/psci.2005.16.issue-1.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, M. W. Johnson, U. D. McCann, and R. Jesse. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22 (6):621–32. doi:10.1177/0269881108094300.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187 (3):268–83. doi:10.1007/s00213-006-0457-5.
   PubMed Web of Science ®Google Scholar
• Grob, C. S., A. L. Danforth, G. S. Chopra, M. Hagerty, C. R. McKay, A. L. Halberstadt, and G. R. Greer. 2011. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. JAMA Psychiatry 68 (1):71–78. doi:10.1001/archgenpsychiatry.2010.
   Google Scholar
• Hallock, R. M., A. Dean, Z. A. Knecht, J. Spencer, and E. C. Taverna. 2012. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug and Alcohol Dependence 130:245–248. doi:10.1016/j.drugalcdep.2012.11.010.
   PubMed Web of Science ®Google Scholar
• Hanna, J., and T. Manning. 2010. Recollections of Myron Stolaroff and the international foundation for advanced study. https://erowid.org/culture/characters/stolaroff_myron/stolaroff_collection_video1.shtml ( accessed September 2, 2016).
   Google Scholar
• Harman, W., R. McKim, R. Mogar, J. Fadiman, and M. Stolaroff. 1966. Psychedelic agents in creative problem solving: A pilot study. Psychological Reports 19 (1):211–27. doi:10.2466/pr0.1966.19.1.211.
   PubMed Web of Science ®Google Scholar
• Haskell, C. F., D. O. Kennedy, A. L. Milne, K. A. W. Wesnes, and A. B. Scholey. 2008. Cognitive and mood effects of caffeine and theanine alone and in combination. Behavioral Pharmacology 77 (2):113–22. doi:10.1016/j.biopsycho.2007.09.008.
   Web of Science ®Google Scholar
• Hendricks, P., B. Clark, M. Johnson, K. Fontaine, and K. Cropsey. 2014. Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision. Journal of Psychopharmacology 28 (1):62–66. doi:10.1177/0269881113513851.
   PubMed Web of Science ®Google Scholar
• Hendricks, P., C. Thorne, B. Clark, D. Coombs, and M. Johnson. 2015. Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology 29:280–88. doi:10.1177/0269881114565653.
   PubMed Web of Science ®Google Scholar
• Hood, R. W. 1975. The construction and preliminary validation of a measure of reported mystical experience. Journal for the Scientific Study of Religion 14 (1):29–41. doi:10.2307/1384454.
   Web of Science ®Google Scholar
• Hood, Jr., R. W., N. Ghorbani, P. J. Watson, A. F. Ghramaleki, M. N. Bing, H. K. Davison, R. J. Morris, and W. P. Williamson. 2001. Dimensions of the mysticism scale: Confirming the three-factor structure in the United States and Iran. Journal for the Scientific Study of Religion 40 (4):691–705. doi:10.1111/0021-8294.00085.
   Web of Science ®Google Scholar
• Jarosz, A., G. Colflesh, and J. Wiley. 2012. Uncorking the muse: Alcohol intoxication facilitates creative problem solving. Consciousness and Cognition 21 (1):487–93. doi:10.1016/j.concog.2012.01.002.
   PubMed Web of Science ®Google Scholar
• Johnson, M., A. Garcia-Romeu, M. Cosimano, and R. R. Griffiths. 2014. Pilot study of the 5HT2AR psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology 28 (11):983–92. doi:10.1177/0269881114548296.
   PubMed Web of Science ®Google Scholar
• Johnson, M. W., W. A. Richards, and R. R. Griffiths. 2008. Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology 22 (6):603–20. doi:10.1177/0269881108093587.
   PubMed Web of Science ®Google Scholar
• Jones, K., M. Blagrove, and A. C. Parrott. 2009. Cannabis and ecstasy/MDMA: Empirical measures of creativity in recreational users. Journal of Psychoactive Drugs 41 (4):323–29. doi:10.1080/02791072.2009.10399769.
   PubMed Web of Science ®Google Scholar
• Koebler, J. 2015. A brief history of microdosing. November 24. http://motherboard.vice.com/read/a-brief-history-of-microdosing ( accessed March 4, 2016).
   Google Scholar
• Kowal, M., A. Hazekamp, L. Colzato, H. Van Steenbergen, and N. Van Der Wee. 2015. Cannabis and creativity: Highly potent cannabis impairs divergent thinking in regular cannabis users. Psychopharmacology 232 (6):1123–34. doi:10.1007/s00213-014-3749-1.
   PubMed Web of Science ®Google Scholar
• Kuypers, C. P. C., J. Riba, M. de la Fuente Revenga, S. Barker, E. L. Theunissen, J. G. Ramaekers. 2016. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:3395–3403. doi:10.1007/s00213-016-4377-8.
   Web of Science ®Google Scholar
• Leonard, A. 2015. How LSD microdosing became the hot new business trip. Rolling Stone. December 3. http://www.rollingstone.com/culture/features/how-lsd-microdosing-became-the-hot-new-business-trip-20151120 ( accessed February 9, 2016).
   Google Scholar
• MacLean, K. A., M. W. Johnson, and R. R. Griffiths. 2011. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 25 (11):1453–61. doi:10.1177/0269881111420188.
   PubMed Web of Science ®Google Scholar
• Miller, W. R. 2004. The phenomenon of quantum change. Journal of Clinical Psychology/In Session 60:453–60. doi:10.1002/jclp.20000.
   PubMed Web of Science ®Google Scholar
• Newberg, A., A. Alavi, M. Baime, M. Pourdehnad, J. Santanna, and E. d’Aquili. 2001. The measurement of regional cerebral blood flow during the complex cognitive task of meditation: A preliminary SPECT study. Psychiatry Research: Neuroimaging 106 (2):113–22. doi:10.1016/S0925-4927(01)00074-9.
   PubMed Web of Science ®Google Scholar
• Noble, E. P., M. A. Runco, and T. Z. Ozkaragoz. 1993. Creativity in alcoholic and nonalcoholic families. Alcohol 10 (4):317–22. doi:10.1016/0741-8329(93)90012-D.
   PubMed Web of Science ®Google Scholar
• Nutt, D., L. King, and D. Nichols. 2013. Effects of schedule I drug laws on neuroscience research and treatment innovation. Nature Reviews Neuroscience 14 (8):577–85. doi:10.1038/nrn3530.
   PubMed Web of Science ®Google Scholar
• Oppezzo, M., and D. Schwartz. 2014. Give your ideas some legs: The positive effects of walking on creative thinking. Journal of Experimental Psychology: Learning, Memory, and Cognition 40 (4):1142–52. doi:10.1037/a0036577.
   PubMed Web of Science ®Google Scholar
• Preacher, K. J., and A. F. Hayes. 2008. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods 40 (3):879–91. doi:10.3758/BRM.40.3.879.
   PubMed Web of Science ®Google Scholar
• Raingruber, B., and C. Robinson. 2007. The effectiveness of tai chi, yoga, meditation, and Reiki healing sessions in promoting health and enhancing problem solving abilities of registered nurses. Issues in Mental Health Nursing 28 (10):1141–55. doi:10.1080/01612840701581255.
   PubMedGoogle Scholar
• Schafer, G., A. Feilding, C. J. A. Morgan, M. Agathangelou, T. P. Freeman, and V. Curran. 2012. Investigating the interaction between schizotypy, divergent thinking and cannabis use. Consciousness and Cognition 21 (1):292–98. doi:10.1016/j.concog.2011.11.009.
   PubMed Web of Science ®Google Scholar
• Sessa, B. 2008. Is it time to revisit the role of psychedelic drugs in enhancing creativity? Journal of Psychopharmacology 22 (8):821–27. doi:10.1177/0269881108091597.
   PubMed Web of Science ®Google Scholar
• Smith, M. E., and M. Farah. 2011. Are prescription stimulants “smart pills?” The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin 137 (5):717–41. doi:10.1037/a0023825.
   PubMed Web of Science ®Google Scholar
• Tyls, F., T. Palenicek, and J. Horacek. 2014. Psilocybin: Summary of knowledge and new perspectives. European Neuropsychopharmacology 24 (3):342–56. doi:10.1016/j.euroneuro.2013.12.006.
   PubMed Web of Science ®Google Scholar
• Vollenweider, F. X., and M. Kometer. 2010. The neurobiology of psychedelic drugs: Implications for treatment of mood disorders. Nature 11 (9):642–51. doi:10.1038/nrn2884.
   Web of Science ®Google Scholar
• Walsh, R., and C. S. Grob. 2005. Higher wisdom: Eminent elders explore the continuing impact of psychedelics. Albany, NY: State University of New York Press.
   Google Scholar
• Woods, B. 2016. Can very small doses of LSD make you a better worker? I decided to try it. http://www.vox.com/2016/3/2/11115974/lsd-internet-addiction ( accessed March 4, 2016).
   Google Scholar